Almeda Ventures - The Next Generation of HealthTech Investments Investing in Medical Device, Digital Health and Bio-Convergence
קישור חיצוני עבור Almeda Ventures
Tel-Aviv , IL
Now, in Israel, as well!
Another exciting milestone! 📢 Nurami Medical was granted the AMAR certificate for ArtiFascia, our dural repair graft. AMAR is the Israeli medical device regulatory approval by the Ministry of Health. This is the result of a challenging process and of an excellent team effort! Kudos Nurami team! 😎
Almeda Ventures פרסם מחדש את זה
It was great to sit down with Judy Khan Shaw at the NYSE and talk about TailorMed - what we do, what makes us unique and our strategic plans moving forward. Thanks for the opportunity Judy and thanks Poalim Tech for the partnership and great event.
Almeda Ventures פרסם מחדש את זה
Continuing with our series, today’s letter is “I” — for “Investors That Pass” When it comes to securing investment, understanding why some investors pass on opportunities is key to refining your approach. Investment mandates, risk tolerance, and differing views on success play significant roles in these decisions. Gaining insight into these factors can help Medtech companies better align their strategies with investor expectations. At LSI Europe ‘24, our panel "Investors That Pass: An Open Dialogue on Investment Mandates and Definitions of Success," engaged with investors who will openly discuss the factors that lead them to pass on certain opportunities. This panel provided an inside look at how different investors define success and what truly drives their investment decisions. Curious to learn more? The full video recording will be available in the coming weeks. This panel featured: • Fernando Pacheco (Moderator) — Endeavour Vision • Alexei Mlodinow — SPRIG Equity • Diana Saraceni — Panakes Partners • Dr. Irit Yaniv — Almeda Ventures PS: Registration is now open for LSI Europe ‘25 next September 7th - 11th in London. Secure your spot today to take advantage of our best rates and secure your hotel room onsite.
Not just a Balloon! This will protect your body!
ICYMI – Read the compelling outcomes in "Prospective, Randomized Controlled Pivotal Trial of Biodegradable Balloon Rectal Spacer for Prostate Radiation Therapy” published in the Red Journal. Lead author, Dr. Daniel Song, will be presenting more from this study tomorrow at #ASTRO2024 at 2 PM in Session Room 154. https://lnkd.in/gP7tv3M5 #BioProtect #BioProtectBalloon #ProstateCancer #RadiationTherapy #RectalSpacer #SpaceMatters
Together we are strong 🙏💪
For my love and support of #Israel and as Co-Chair of MedTech Malta, I dedicate this panel to the successes, ambitions, and uniqueness of The Start-up Nation of Israel. Panel: Israel's Role in Global MedTech Innovation at Lifeblood & MedTech World's MedTech Malta - www.med-tech.world Thank you for joining me on stage to share why the MedTech World needs to be aware of what Israel brings to the table of innovation and investments: 1) Dr. Irit Yaniv, Co-Founder & CEO of Almeda Ventures 2) Gary Gershony, Founding Managing Partner, BayMed Venture Partners 3) Assaf Barnea, Managing Partner of Sanara Capital & Ventures 4) Michal Fisher, VP of Corporate Development at LifeSci Partners 5) Yoav Fisher, Head of Innovation at HealthIL 6) Shai Policker, Managing Partner at EdgeMed 7) Yuval Mandelbaum, CEO of Discure Technologies After Israel being a part of my life for +15 years, I am excited to have these friends and panelists share with the world of MedTech on why it is as special as I have witnessed it to be. Let's congratulate Yuval Mandelbaum for raising a series A of $16M during challenging times beyond the natural challenges of raising capital - it says a great deal about Yuval and his technology: https://lnkd.in/e_mQm5_U For more insights on Israeli MedTech, check out my old Medtech Money Podcast series where we highlighted: * Gur Roshwalb: https://lnkd.in/eQdiZUar * Yoav Fisher: https://lnkd.in/eQjbUqck * Eyal Lifschitz: https://lnkd.in/etPjxNSK * Daniel Adler: https://lnkd.in/eqy8BU7s * Dan Jacob Gelvan: https://lnkd.in/ehcg8RpM * Yotam Drechsler: https://lnkd.in/eQUVJtxD * Ronit Harpaz: https://lnkd.in/eMH6v8Da With love and support of Israel and being able to highlight The Start-up Nation in Malta, Giovanni Lauricella of Lifeblood Check out our new website www.lifeblood.com
Almeda Ventures פרסם מחדש את זה
Higher quality of suturing ✅ Improved surgeon ergonomics ✅ Increased hospital revenue ✅ Visit the FlexDex Surgical booth at the American Hernia Society this week to learn more about the advantages of using the AXIUS Needle Driver for laparoscopic hernia repair. Not in Chicago? Contact us at info@flexdex.com to schedule a demo.
Join us doe this interesting dialogue! LSI
When it comes to securing investment, understanding why some investors pass on opportunities is key to refining your approach. Investment mandates, risk tolerance, and differing views on success play significant roles in these decisions. Gaining insight into these factors can help Medtech companies better align their strategies with investor expectations. In our latest LSI Europe '24 panel, "Investors That Pass: An Open Dialogue on Investment Mandates and Definitions of Success," we’ll engage with investors who will openly discuss the factors that lead them to pass on certain opportunities. This panel will provide an inside look at how different investors define success and what truly drives their investment decisions. We’ll hear perspectives from: • Alexei Mlodinow (Moderator) — SIA (Acquired by Integra LifeSciences)) • Diana Saraceni — Panakes Partners • Dr. Irit Yaniv — Almeda Ventures Join us at LSI Europe ‘24 this September 16-20th to see more panel sessions like this and connect with hundreds of global Medtech and Healthtech leaders in Sintra, Portugal. Apply on our website today while space is still available.
One of our best protfolio companies!
A few months since we have launched in the US - ArtiFascia, our innovative dural repair graft continues to reach satisfied users! One of them is Prof. Konstantin Slavin from University of Illinois Chicago. He was one of our very first users. His words say it all - watch below!
Almeda Ventures פרסם מחדש את זה
Initial responses to ArtiFascia are exciting!
Great testimonial below! Dr. Michael Groff has been the first user of ArtiFascia, our dural repair graft, which was launched earlier this year. His words say everything 💡 ArtiFascia has been used in dozens of surgeries successfully, showing exceptional versatility of applications and excellent clinical results. #neurosurgery #artifascia https://lnkd.in/dtCWXiEV
Almeda Ventures פרסם מחדש את זה
Great testimonial below! Dr. Michael Groff has been the first user of ArtiFascia, our dural repair graft, which was launched earlier this year. His words say everything 💡 ArtiFascia has been used in dozens of surgeries successfully, showing exceptional versatility of applications and excellent clinical results. #neurosurgery #artifascia https://lnkd.in/dtCWXiEV